A patient is commenced on a novel chemotherapeutic agent for colorectal cancer. | Medibuddy
19th May 2025

A patient is commenced on a novel chemotherapeutic agent for colorectal cancer.

A patient is commenced on a novel chemotherapeutic agent for colorectal cancer. They develop deranged liver function tests; other causes of liver injury are ruled out, and diagnosis of drug-induced liver injury is made. Which one of the following options would favour the classification of this liver injury as a ‘predictable’ DILI?

Select the SINGLE most appropriate option from the list below. Select ONE option only.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.